chevron_leftBack
As of 13 June 2026, Turnstone Biologics Corp. has a market cap of $8.21M USD, ranking #42293 globally and #5440 in the United States.
It ranks #3743 in the Healthcare sector, and #736 in the Biotechnology industry.
Key Stats
Market Cap
$8.21MUSD
Enterprise Value
-$8.06MUSD
EBITDA (TTM)
-$44.16MUSD
Net Income (TTM)
-$47.2MUSD
PB Ratio
0.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Sammy Farah
open_in_new
Employees
14
Founded
2015
IPO
21 Jul 2023
Website
turnstonebio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 0.4% | -2.8% | 6.8% | -20% | -84% |
News
Loading...
TSBX Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
TSBX
Turnstone Biologics Corp
ISIN: US90042W1009
Shares Out.:
Shares Outstanding:
23.14M1
Shares Float:
17.231M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
0.3550 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Turnstone Biologics Corp.
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
2M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
2M%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
336K%
|
-
|
|
NYSE: IQV
|
$26.3B
320K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
305K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
221K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
582K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
546K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
516K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
515K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
342K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
313K%
|
-
|
chevron_leftBack